2031 - 2040 of 9134 Results
Title
Year
- Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness2020OPENTitle: Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime SleepinessJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 1353End Page: 1353Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.01353Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.01353/pdfCitation Count: 18
-
OPENTitle: Genome-wide Analysis of Motor Progression in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 5Start Page: e200092End Page: e200092Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/nxg.0000000000200092Best OA location URL: https://ng.neurology.org/content/nng/9/5/e200092.full.pdfCitation Count: 11
-
OPENTitle: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteinsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 120End Page: 120Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00564-3Best OA location URL: https://www.nature.com/articles/s41531-023-00564-3.pdfCitation Count: 47
-
OPENTitle: Analysis of common and rare VPS13C variants in late-onset Parkinson diseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 1Start Page: 385End Page: 385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000385Best OA location URL: https://ng.neurology.org/content/nng/6/1/385.full.pdfCitation Count: 29
-
OPENTitle: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up studyJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18538End Page: e18538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538Best OA location URL: http://www.cell.com/article/S2405844023057468/pdfCitation Count: 0
- Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s disease2019OPENTitle: Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 8Start Page: 2417End Page: 2431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz164Best OA location URL: https://academic.oup.com/brain/article-pdf/142/8/2417/32742258/awz164.pdfCitation Count: 63
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 10End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 97
- Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study2019OPENTitle: Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort studyJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 3Start Page: 314End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-321794Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/3/314.full.pdfCitation Count: 80
-
OPENTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/9716317.pdfCitation Count: 19
-
OPENTitle: Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinicJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 268End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-023-02558-4Best OA location URL: https://www.nature.com/articles/s41398-023-02558-4.pdfCitation Count: 19